Vectorite Biomedical, Inc.(TW:4170)
NT$11.00+0.05 (+0.00%)
TW:4170
Vectorite Biomedical, Inc. Revenue
NT$11.00
At close:+0.05 (+0.00%)
Vectorite Biomedical, Inc. (4170) Revenue
Vectorite Biomedical, Inc. Revenue
Vectorite Biomedical, Inc. had a revenue of 27.13M in the quarter ending Jun 30, 2026, with -1.96%. This bring the company's revenue in the last twelve months to 54.81M, Decreased 10.74%. In the fiscal year ending Dec 31, 2025, Vectorite Biomedical, Inc. had annual revenue of 61.41M with 6.29% growth.
- Revenue (ttm)
- 54.81M
- Revenue Growth
- -19.28%
- P/S Ratio
- 7.84
- Revenue/Employee
- TWD 1,428,047
- Employees
- 43
- Market Cap
- TWD 481.49M
Revenue Chart
Vectorite Biomedical, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 61.41M | 3.64M | 6.29% |
| Dec 31, 2024 | 57.77M | 1.92M | 3.43% |
| Dec 31, 2023 | 55.85M | 12.94M | 30.15% |
| Dec 31, 2022 | 42.91M | 14.14M | 49.16% |
| Dec 31, 2021 | 28.77M | 4.23M | 17.22% |
| Dec 31, 2020 | 24.54M | -2.00M | -7.52% |
| Dec 31, 2019 | 26.54M | -179.79M | -87.14% |
| Dec 31, 2018 | 206.33M | 61.89M | 42.85% |
| Dec 31, 2017 | 144.44M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.